Aura Biosciences, Inc. Diluted Shares Outstanding (Weighted Average)
Aura Biosciences, Inc. (AURA) reported Diluted Shares Outstanding (Weighted Average) of 94.86 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 94.86M shares, a 63.51% increase year-over-year.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 67.45M shares, a 34.56% increase year-over-year.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 67.10M shares, a 34.37% increase year-over-year.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 65.94M shares, a 32.77% increase year-over-year.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 60.34M shares, a 21.52% increase from fiscal 2024.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 49.65M shares, a 25.32% increase from fiscal 2023.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 39.62M shares, a 32.34% increase from fiscal 2022.
- Aura Biosciences, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 29.94M shares, a 480.18% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 94.86M shares 10-Q · filed 2026-08-11 | 81.23M shares 10-Q · filed 2026-08-11 | 76.47M shares derived: average of 3 quarters · filed 2026-08-11 | 73.84M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 67.45M shares 10-Q · filed 2026-05-11 | 67.27M shares derived: average of 2 quarters · filed 2026-05-11 | 66.83M shares derived: average of 3 quarters · filed 2026-05-11 | 64.62M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 67.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 66.52M shares derived: average of 2 quarters · filed 2026-03-30 | 63.68M shares derived: average of 3 quarters · filed 2026-08-11 | 60.34M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 65.94M shares 10-Q · filed 2025-11-13 | 61.98M shares derived: average of 2 quarters · filed 2026-08-11 | 58.08M shares 10-Q · filed 2025-11-13 | 56.00M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 58.02M shares 10-Q · filed 2026-08-11 | 54.09M shares 10-Q · filed 2026-08-11 | 52.69M shares derived: average of 3 quarters · filed 2026-08-11 | 51.94M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 50.13M shares 10-Q · filed 2026-05-11 | 50.03M shares derived: average of 2 quarters · filed 2026-05-11 | 49.91M shares derived: average of 3 quarters · filed 2026-05-11 | 49.82M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 49.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 49.80M shares derived: average of 2 quarters · filed 2026-03-30 | 49.72M shares derived: average of 3 quarters · filed 2026-03-30 | 49.65M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 49.66M shares 10-Q · filed 2025-11-13 | 49.61M shares derived: average of 2 quarters · filed 2025-11-13 | 49.55M shares 10-Q · filed 2025-11-13 | 48.33M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 49.55M shares 10-Q · filed 2025-08-13 | 49.50M shares 10-Q · filed 2025-08-13 | 47.88M shares derived: average of 3 quarters · filed 2025-08-13 | 45.46M shares derived: average of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 49.45M shares 10-Q · filed 2025-05-15 | 47.05M shares derived: average of 2 quarters · filed 2025-05-15 | 44.10M shares derived: average of 3 quarters · filed 2025-05-15 | 42.54M shares derived: average of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 44.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 41.42M shares derived: average of 2 quarters · filed 2025-03-24 | 40.23M shares derived: average of 3 quarters · filed 2025-03-24 | 39.62M shares 10-K · filed 2025-03-24 |
| 2023-09-30 | 38.19M shares 10-Q · filed 2024-11-12 | 38.02M shares derived: average of 2 quarters · filed 2024-11-12 | 37.94M shares 10-Q · filed 2024-11-12 | 36.46M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 37.86M shares 10-Q · filed 2024-08-08 | 37.82M shares 10-Q · filed 2024-08-08 | 35.88M shares derived: average of 3 quarters · filed 2024-08-08 | 34.23M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 37.78M shares 10-Q · filed 2024-05-09 | 34.90M shares derived: average of 2 quarters · filed 2024-05-09 | 33.02M shares derived: average of 3 quarters · filed 2024-05-09 | 32.08M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 32.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 30.64M shares derived: average of 2 quarters · filed 2024-03-27 | 30.18M shares derived: average of 3 quarters · filed 2024-03-27 | 29.94M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 29.27M shares 10-Q · filed 2023-11-09 | 29.26M shares derived: average of 2 quarters · filed 2023-11-09 | 29.25M shares 10-Q · filed 2023-11-09 | 26.77M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 29.25M shares 10-Q · filed 2023-08-09 | 29.23M shares 10-Q · filed 2023-08-09 | 25.94M shares derived: average of 3 quarters · filed 2023-08-09 | 19.57M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 29.21M shares 10-Q · filed 2023-05-11 | 24.29M shares derived: average of 2 quarters · filed 2023-05-11 | 16.34M shares derived: average of 3 quarters · filed 2023-05-11 | 12.36M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 19.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 9.90M shares derived: average of 2 quarters · filed 2023-03-15 | 6.75M shares derived: average of 3 quarters · filed 2023-03-15 | 5.16M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 441.45K shares 10-Q · filed 2022-11-10 | 439.46K shares derived: average of 2 quarters · filed 2022-11-10 | 426.60K shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 437.46K shares 10-Q · filed 2022-08-11 | 419.06K shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |